Irenic Capital Management LP Sells 163,940 Shares of Sotera Health Company $SHC

Irenic Capital Management LP trimmed its holdings in shares of Sotera Health Company (NASDAQ:SHCFree Report) by 4.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,548,071 shares of the company’s stock after selling 163,940 shares during the quarter. Sotera Health accounts for about 5.8% of Irenic Capital Management LP’s portfolio, making the stock its largest position. Irenic Capital Management LP owned approximately 1.25% of Sotera Health worth $55,811,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of SHC. EverSource Wealth Advisors LLC grew its holdings in shares of Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after buying an additional 2,935 shares during the last quarter. Versant Capital Management Inc grew its stake in Sotera Health by 117.6% during the 3rd quarter. Versant Capital Management Inc now owns 2,535 shares of the company’s stock valued at $40,000 after purchasing an additional 1,370 shares during the last quarter. Fairway Wealth LLC purchased a new stake in Sotera Health during the 3rd quarter valued at about $57,000. CWM LLC increased its holdings in shares of Sotera Health by 194.6% in the third quarter. CWM LLC now owns 5,191 shares of the company’s stock valued at $82,000 after purchasing an additional 3,429 shares during the period. Finally, Quadrant Capital Group LLC acquired a new position in shares of Sotera Health in the third quarter valued at about $86,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Price Performance

Shares of Sotera Health stock opened at $13.41 on Monday. The firm has a market cap of $3.81 billion, a PE ratio of 49.67 and a beta of 1.84. The business has a 50-day moving average price of $17.35 and a 200 day moving average price of $16.75. The company has a quick ratio of 2.24, a current ratio of 2.46 and a debt-to-equity ratio of 3.66. Sotera Health Company has a twelve month low of $9.53 and a twelve month high of $19.85.

Sotera Health (NASDAQ:SHCGet Free Report) last posted its quarterly earnings data on Tuesday, February 24th. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The business had revenue of $303.44 million during the quarter, compared to analysts’ expectations of $300.68 million. During the same period in the previous year, the business earned $0.21 earnings per share. The business’s revenue was up 4.6% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Sell-side analysts predict that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on SHC. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Sotera Health in a report on Monday, December 29th. Piper Sandler raised shares of Sotera Health from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $17.00 to $24.00 in a research report on Friday, January 9th. Royal Bank Of Canada started coverage on shares of Sotera Health in a research note on Thursday, January 8th. They set an “outperform” rating and a $24.00 price objective for the company. Citigroup upped their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a report on Tuesday, February 24th. Finally, William Blair started coverage on shares of Sotera Health in a research note on Thursday, December 18th. They issued an “outperform” rating on the stock. Eight analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $20.43.

Check Out Our Latest Report on SHC

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction on Friday, March 6th. The shares were sold at an average price of $15.27, for a total transaction of $152,700,000.00. Following the sale, the director owned 12,735,301 shares of the company’s stock, valued at $194,468,046.27. The trade was a 43.98% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 55.12% of the company’s stock.

Sotera Health Company Profile

(Free Report)

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

Featured Articles

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health Company (NASDAQ:SHCFree Report).

Institutional Ownership by Quarter for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.